Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRODIGE 7: HIPEC with Oxaliplatin for Colorectal Peritoneal Carcinomatosis
NCT00769405Phase 3Completed
- Sponsor
- Unicancer
- Start
- Feb 2008
- Primary completion
- Dec 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin in colorectal cancer (CRC), sponsored by Unicancer. Started Feb 2008; status: completed.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00769405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00769405.